Skip to content
PICO Portalanswers from OpenAlex

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

PaperCitations, authors & open-access status

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer have?

PICO Portalcitation count

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer has 6,385 citations in the OpenAlex counts PICO Portal stores.

When was A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer published?

PICO Portalyear

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer has 2004 year in the PICO Portal index.

What is the open-access status of A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer?

PICO Portaloa status

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer has bronze oa status in the PICO Portal index.

What is the DOI of A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer?

PICO Portaldoi

The DOI for A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer is on the source record.

What is the PMID of A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer?

PICO Portalpmid

The PMID for A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer is on the source record.

What is the OpenAlex record for A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer?

PICO Portalopenalex

The OpenAlex for A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial